Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orthokin trial in knee osteoarthritis
NL-OMON22051Active, not recruiting
- Sponsor
- UMC Utrecht Department of Orthopaedics
- Start
- Jan 2004
- Countries
- 1
01
Overview
Randomised, double-blind trial in knee osteoarthritis (OA) comparing Orthokin with Placebo (2 arms). Primary endpoint: Questionnaire-based effectiveness at 12 months. Started Jan 2004; status: active, not recruiting.
02
Drugs
autologous conditioned serum
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NL-OMON22051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22051.